Sensei Biotherapeutics

Contributing Author

Recent Articles by Sensei Biotherapeutics

Oct-30	Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value SNSE GlobeNewswire
Oct-17	Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025 SNSE GlobeNewswire
Sep-23	Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025 SNSE GlobeNewswire
Sep-03	Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference SNSE GlobeNewswire
Aug-05	Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update SNSE GlobeNewswire
Jul-30	Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025 SNSE GlobeNewswire
Jun-13	Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split SNSE GlobeNewswire
May-06	Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress SNSE GlobeNewswire